tradingkey.logo

tradingkey.logo
怜玢


eXoZymes Inc

EXOZ
りォッチリストに远加
3.830USD
-0.170-4.25%
終倀 11-13 16:00ET
35.62M時䟡総額
損倱額盎近12ヶ月PER

eXoZymes Incに぀いお 䌁業名

eXoZymes Inc, formerly Invizyne Technologies, Inc., is an artificial intelligence (AI) engineered enzyme that can transform sustainable feedstock into essential chemicals, medicines, and biofuels. The Company has developed a platform that offers the tools and insight to control and optimize nature’s own biological processes, enabling their partners to replace traditional chemical production methods with a new sustainable and non-polluting alternative. The Exozymes are advanced enzymes engineered using AI to thrive in a bioreactor outside of living cells.

eXoZymes Inc プロフィヌル


䌁業コヌドEXOZ
䌚瀟名eXoZymes Inc
䞊堎日Nov 13, 2024
最高経営責任者「CEO」Heltzen (Michael)
埓業員数31
蚌刞皮類Ordinary Share
決算期末Nov 13
本瀟所圚地750 Royal Oaks Dr
郜垂MONROVIA
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号91016
電話番号16264151488
りェブサむトhttps://exozymes.com/
䌁業コヌドEXOZ
䞊堎日Nov 13, 2024
最高経営責任者「CEO」Heltzen (Michael)

eXoZymes Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. Paul Hideo Opgenorth, Ph.D.
Dr. Paul Hideo Opgenorth, Ph.D.
Vice President - Development
Vice President - Development
678.58K
+4.58%
Mr. Fouad Nawaz
Mr. Fouad Nawaz
Vice President - Finance
Vice President - Finance
9.49K
--
Mr. Michael Heltzen
Mr. Michael Heltzen
President, Chief Executive Officer
President, Chief Executive Officer
8.84K
-9.67%
Dr. Tyler Korman, Ph.D.
Dr. Tyler Korman, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Mr. Christopher A. (Chris) Marlett
Mr. Christopher A. (Chris) Marlett
Chairman of the Board
Chairman of the Board
--
--
Mr. Anthony DiGiandomenico
Mr. Anthony DiGiandomenico
Independent Director
Independent Director
--
--
Dr. James U. Bowie, Ph.D.
Dr. James U. Bowie, Ph.D.
Independent Director
Independent Director
--
--
Dr. James J. (Jim) Lalonde
Dr. James J. (Jim) Lalonde
Independent Director
Independent Director
--
--
Dr. Lon Edward Bell, Ph.D.
Dr. Lon Edward Bell, Ph.D.
Independent Director
Independent Director
--
--
Mr. Lasse H. Goerlitz
Mr. Lasse H. Goerlitz
Vice President - Communications
Vice President - Communications
--
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. Paul Hideo Opgenorth, Ph.D.
Dr. Paul Hideo Opgenorth, Ph.D.
Vice President - Development
Vice President - Development
678.58K
+4.58%
Mr. Fouad Nawaz
Mr. Fouad Nawaz
Vice President - Finance
Vice President - Finance
9.49K
--
Mr. Michael Heltzen
Mr. Michael Heltzen
President, Chief Executive Officer
President, Chief Executive Officer
8.84K
-9.67%
Dr. Tyler Korman, Ph.D.
Dr. Tyler Korman, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Mr. Christopher A. (Chris) Marlett
Mr. Christopher A. (Chris) Marlett
Chairman of the Board
Chairman of the Board
--
--
Mr. Anthony DiGiandomenico
Mr. Anthony DiGiandomenico
Independent Director
Independent Director
--
--

よくある質問

eXoZymes Incの䞊䜍5名の株䞻は誰ですか


eXoZymes Incの䞊䜍5名の株䞻は以䞋のずおりです。Dr. Paul Hideo Opgenorth, Ph.D.

eXoZymes IncEXOZの株匏を保有しおいる機関の数はいく぀ですか


2026Q1時点で、eXoZymes Incの株匏を保有しおいる機関は13瀟あり、保有株匏の総垂堎䟡倀は玄94.24Kで、党䜓の1.11%を占めおいたす。2025Q4ず比范しお、機関の持ち株は16676.00増加しおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。